It is on the basis of this research that Li et al. (2023) constructed a prognostic model for glioma patients, which incorporates copper metabolism-related genes including LOXL3, providing valuable references for the diagnosis and treatment of glioma patients. Here, LOXL3 is linked to central nervous system cancer.